Note 7 - Stockholders' Deficit (Details) |
3 Months Ended |
---|---|
Mar. 31, 2021
$ / shares
shares
| |
Equity [Abstract] | |
Outstanding, beginning | shares | 221,041 |
Granted | shares | 5,192,250 |
Forfeited/canceled | shares | 0 |
Exercised | shares | (94,424) |
Outstanding, ending | shares | 5,318,867 |
Exercisable, ending | shares | 5,318,867 |
Outstanding, beginning | $ / shares | $ 3.40 |
Granted | $ / shares | 5.50 |
Forfeited/canceled | $ / shares | 0.00 |
Exercised | $ / shares | 3.23 |
Outstanding, ending | $ / shares | 5.44 |
Exercisable, ending | $ / shares | $ 5.44 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|